![](/img/cover-not-exists.png)
Sodium glucose co-transporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline
Tobe, Kazuyuki, Suganami, Hideki, Kaku, KoheiLanguage:
english
Journal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.12761
Date:
October, 2017
File:
PDF, 359 KB
english, 2017